Skip to main content
All lobbying filings

NEUROCRINE BIOSCIENCES, INC

Lobbying for NEUROCRINE BIOSCIENCES, INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $940,000.00 expenses · posted Apr 20, 2026

Official filing document

 Bills named in this filing 6
  • HR 7024
    Hemp Planting Predictability Act
  • HR 946
    ORPHAN Cures Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 832
    EPIC Act of 2025
  • HR 3432
    TDS Research Act of 2025
  • HR 7623
    Freedom House Ambulance Service Congressional Gold Medal Act
 Lobbying activity 4
Taxation/Internal Revenue Code

Issues related to the Research and Development (R&D) tax credit including the Tax Relief for American Families and Workers Act of 2024, H.R. 7024. Issues related to the Orphan Drug Tax Credit.

Medicare/Medicaid

Issues related to implementation of the Inflation Reduction Act, P.L. 117-169, including potential changes to the structure of and reimbursement for Medicare Part D. H.R. 946 - Orphan Cures Act H.R. 1492 / S. 832 - Ensuring Pathways to Innovative Cures (EPIC) Act Issues related to drug pricing

Health Issues

Regulatory and legislative healthcare issues related to pharmaceutical development, approval, reimbursement, and patient access. Issues related to the screening, diagnosis, and treatment of Tardive Dyskinesia. Issues related to telehealth including the Telemental Health Care Access Act of 2023, H.R. 3432, and the Telehealth Modernization Act of 2024, H.R. 7623. Issues related to the Rare Pediatric Priority Review Voucher Program.

Budget/Appropriations

Support appropriations report language and funding to encourage additional support from the Department of Health and Human Services and the Department of Veterans Affairs for physical conditions associated with mental illness, such as Tardive Dyskinesia.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem